Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Pharmaceutical Cold Chain Logistics Market: By Product, By Service, and Geography
Pharmaceutical Cold Chain Logistics Market: By Product, By Service, and Geography
Pharmaceutical Cold Chain Logistics Market size was valued at US$ 11,271.6 million in 2022 and is expected to grow at a 9.5% CAGR from 2024 to 2030. Pharmaceutical cold chain logistics refers to the storage and handling and transport of temperature sensitive drugs or products. Most of the drugs are stored in a controlled environment between 59 °F and 77 °F. vaccines and other biologicals often need to be stored in a temperature between 35.6 °F and 46.4 °F. and messenger RNA vaccines need to be stored at -4 °F or even -94 °F. This type of cold stored drugs or biologicals are used in the treatment of chronic disorders. Thus, increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disease are expected to drive the growth of pharmaceutical cold chain logistics market over the forecast period.
In addition, increasing demand for personalized medicines and biologicals, and advancement in technologies and logistics infrastructure are expected to boost the growth of pharmaceutical cold chain logistics market at a significant rate. Furthermore, the rising healthcare expenditure and government initiatives to improve healthcare access and its quality are anticipated to further propel the growth of pharmaceutical cold chain logistics market over the forecast period.
However, the factors like, high cost associated with the pharmaceutical cold chain logistics, lack of standardization and regulatory compliance, strict regulations for transportation and storage of pharmaceutical products are expected to hinder the growth of pharmaceutical cold chain logistics market over the forecasted years. Moreover, the growing demand for temperature-sensitive vaccines and biologics, adoption of block chain technology for supply chain management are anticipated to open up vast opportunities to the market players in the growth of pharmaceutical cold chain logistics market over the forecast period.
Study Period
2024-2030Base Year
2023CAGR
9.5%Largest Market
Asia PacificFastest Growing Market
North America
Increase in R&D investments in biopharmaceutical industry, sales of temperature sensitive pharma and biopharma products are drive the growth of pharmaceutical cold chain logistics market. The stringent government regulations to maintain the desired storage conditions are expected to increase the pharmaceutical cold chain logistics market. The increased import and export activities between the countries expected to play a key role in the development of the market. The advancements in the technology in case of packaging is expected to boost the pharmaceutical cold chain logistics market. However, the high cost involved in the transportation, temperature fluctuations in the refrigerated transportation is expected to hinder the growth of the pharmaceutical cold chain logistics market.
Geographically, Asia Pacific region held the major market share in 2022 and is expected to dominate the global pharmaceutical cold chain logistics market in the forecasted years. North America cold chain logistics market is expected to dominate the market due to adoption of advanced equipment in cold chain logistics. The developing countries are implementing regulations on the safety and health. India is focused on the improvement of storage infrastructure after increase in FDI limit by the government. The technological advancements in the developing countries are expected to offer enormous opportunities to the vendors in the Asia Pacific. The advanced healthcare infrastructure enables increase imports and exports using the pharmaceutical cold chain logistics.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2022 |
US$ 11,271.6 million |
|
Market CAGR |
9.5% |
|
By Product Type |
|
|
By Service |
|
|
By Region |
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa (MEA)
|
Download Free Sample Report
The Pharmaceutical Cold Chain Logistics Market is growing at a CAGR of 9.5% over the forecast period
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1.Executive Summary |
| 2.Global Pharmaceutical Cold Chain Logistics Market Introduction |
| 2.1.Global Pharmaceutical Cold Chain Logistics Market - Taxonomy |
| 2.2.Global Pharmaceutical Cold Chain Logistics Market - Definitions |
| 2.2.1.Product |
| 2.2.2.Service |
| 2.2.3.Route of Administration |
| 2.2.4.Region |
| 3.Global Pharmaceutical Cold Chain Logistics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Pharmaceutical Cold Chain Logistics Market Analysis, 2019-2023 and Forecast 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Pharmaceutical Cold Chain Logistics Market By Product, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 5.1. Pharmaceuticals |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Biopharmaceuticals |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Others |
| 5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Pharmaceutical Cold Chain Logistics Market By Service, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 6.1. Transportation |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Packaging |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Global Pharmaceutical Cold Chain Logistics Market By Route of Administration, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 7.1. Injection |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Nasal Spray |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8.Global Pharmaceutical Cold Chain Logistics Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Pharmaceutical Cold Chain Logistics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 9.1. Product Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Pharmaceuticals |
| 9.1.2.Biopharmaceuticals |
| 9.1.3.Others |
| 9.2. Service Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Transportation |
| 9.2.2.Packaging |
| 9.3. Route of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Injection |
| 9.3.2.Nasal Spray |
| 9.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Pharmaceutical Cold Chain Logistics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 10.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Pharmaceuticals |
| 10.1.2.Biopharmaceuticals |
| 10.1.3.Others |
| 10.2. Service Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Transportation |
| 10.2.2.Packaging |
| 10.3. Route of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Injection |
| 10.3.2.Nasal Spray |
| 10.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11.Asia Pacific (APAC) Pharmaceutical Cold Chain Logistics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Pharmaceuticals |
| 11.1.2.Biopharmaceuticals |
| 11.1.3.Others |
| 11.2. Service Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Transportation |
| 11.2.2.Packaging |
| 11.3. Route of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Injection |
| 11.3.2.Nasal Spray |
| 11.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Pharmaceutical Cold Chain Logistics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Pharmaceuticals |
| 12.1.2.Biopharmaceuticals |
| 12.1.3.Others |
| 12.2. Service Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Transportation |
| 12.2.2.Packaging |
| 12.3. Route of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Injection |
| 12.3.2.Nasal Spray |
| 12.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Pharmaceutical Cold Chain Logistics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 13.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Pharmaceuticals |
| 13.1.2.Biopharmaceuticals |
| 13.1.3.Others |
| 13.2. Service Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Transportation |
| 13.2.2.Packaging |
| 13.3. Route of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Injection |
| 13.3.2.Nasal Spray |
| 13.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.DB Schenker (Germany) |
| 14.2.2.Swire Group (U.K) |
| 14.2.3.FedEx (U.S) |
| 14.2.4.Kuehne + Nagel (Switzerland) |
| 14.2.5.VersaCold Logistics Services (Canada) |
| 14.2.6.Lineage Logistics (U.S) |
| 14.2.7.Americold Logistics (U.S) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.